查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1522235

2024年体外肺部模型全球市场报告

In-Vitro Lung Model Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

体外肺模型市场规模预计在未来几年将呈指数级增长，预计到2028年将增长至9.6亿美元，复合年增长率为21.1%。预测期内的预期成长受到多种因素的推动，特别是药物开发的需求、临床前测试的升级、对呼吸毒理学认识的提高、再生医学的大力投入、日益增长的环境问题，这与以下因素有关老年人口的增加。预测期内的主要特异性包括药物测试需求的增加、3D列印和器官晶片技术的进步、人工智慧和机器学习的整合、感测器和监测设备的引入以及各种非药物应用的开发。

临床试验的激增预计将在未来几年推动体外肺模型市场的成长。临床试验是一项评估新医学方法对人类有效性的研究。临床研究的成长是由对先进医学不断增长的需求、不断增长的医疗保健需求以及对复杂健康挑战的创新解决方案的探索所推动的。体外肺模型提供了一个受控环境来检查物质如何影响肺组织，可用于测试药物、评估毒性、建模疾病和了解疾病机制，并在临床试验中发挥重要作用。例如，根据美国临床试验註册中心 ClinicalTrials.gov 的数据，截至 2024 年 1 月，全球整体註册的临床试验数量为 477,230 项，高于 2022 年的 437,508 项。因此，越来越多的临床试验正在刺激体外肺部模型市场。

体外肺模型市场的主要参与者正在开发 3D 呼吸组织模型，以提高生理相关性和模型复杂性。这些模型是透过在专门的环境中培养选定的呼吸细胞而创建的，使它们能够形成模仿呼吸系统功能和形态的3D结构。这为研究和药物测试提供了一个更生理相关的平台。例如，2023年4月，美国生物技术公司MatTek公司推出了EpiNasal，这是一种由原代人类鼻上皮细胞製成的创新3D呼吸组织模型。 EpiNasal 再现鼻上皮的3D结构和功能，包括产生黏液的杯状细胞、功能性紧密连接和跳动的纤毛。 EpiNasal 简介扩展了 MatTek 的 3D 呼吸组织模型范围，并提供了一个用于研究药物、化学物质、病原体和消费品对人体呼吸系统影响的综合系统。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 市场促进和限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年市场规模表现与成长
  • 市场规模预测与成长，2023-2028，2033F

第六章 市场细分

  • 全球体外肺模型市场：按类型分類的表现和预测，2018-2023、2023-2028F、2033F
  • 二维 (2D) 模型
  • 3D(3D) 模型
  • 全球体外肺模型市场：按应用分類的表现和预测，2018-2023、2023-2028F、2033F
  • 药物发现和毒理学研究
  • 生理学调查
  • 3D(3D) 模型开发
  • 其他的
  • 全球体外肺模型市场：最终用户的表现和预测，2018-2023、2023-2028F、2033F
  • 学术研究所
  • 製药和生物技术公司
  • 其他的

第 7 章 区域/国家分析

  • 全球体外肺模型市场：按地区分類的表现和预测，2018-2023、2023-2028F、2033F
  • 全球体外肺模型市场：按国家分類的表现和预测，2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 体外肺部模型市场：竞争格局
  • 体外肺模型市场：公司简介
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • PerkinElmer Inc.
    • Charles River Laboratories International Inc.
    • Varian Medical Systems Inc.

第31章 其他大型创新企业

  • Epithelix
  • The Charles Stark Draper Laboratory Inc.
  • STEMCELL Technologies
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero
  • Emulate Inc.
  • PhoenixBio Co. Ltd.
  • Newcells Biotech
  • CN Bio Innovations Ltd.
  • Mimetas
  • Cyfuse Biomedical KK
  • 3D Biotek LLC
  • AlveoliX AG
  • AxoSim Technologies LLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r18388

An in vitro lung model is a scientific construct devised to replicate the cellular, structural, and functional characteristics of the human lung within a controlled laboratory setting. These models empower researchers to explore disease progression, identify biomarkers, and evaluate treatment effectiveness. They serve as invaluable instruments for advancing our comprehension of lung biology, refining therapeutic approaches, and enhancing health outcomes.

The primary classifications of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model presents a simplified depiction of lung cells and tissue on a flat surface, employed in fundamental research and preliminary substance testing. They find utility across various domains such as drug discovery, toxicology assessments, physiological investigations, as well as the advancement of three-dimensional (3D) model methodologies. These models are utilized by academic research institutions, pharmaceutical and biotechnology firms, among others.

The in vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in vitro lung model market statistics, including the in vitro lung model industry global market size, regional shares, competitors with in vitro lung model market share, detailed in vitro lung model market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro lung model industry. These in vitro lung model market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in vitro lung model market size has grown exponentially in recent years. It will grow from $0.37 billion in 2023 to $0.44 billion in 2024 at a compound annual growth rate (CAGR) of 21%. The expansion observed during the historical period can be credited to several factors, including the rising incidence of respiratory ailments, heightened attention to personalized medicine, increased exploration of drug repurposing, a focus on precision medicine methodologies, and heightened recognition of environmental health hazards.

The vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $0.96 billion in 2028 at a compound annual growth rate (CAGR) of 21.1%. The anticipated growth in the forecast period can be linked to various factors, notably the demand for drug development, the escalation in preclinical testing, heightened awareness regarding respiratory toxicology, a concentrated effort on regenerative medicine, escalating environmental apprehensions, and the rising population of older adults. Key trends expected in the forecast period encompass heightened demand for drug testing, advancements in 3D printing and organ-on-chip technologies, the integration of AI and machine learning, incorporation of sensors and monitoring apparatuses, diversification of applications beyond pharmaceuticals, and the formulation of disease-specific models.

The surge in clinical studies is anticipated to drive growth in the in vitro lung model market in the future. Clinical trials are investigations that evaluate the effectiveness of new medical approaches in human subjects. This increase in clinical studies is propelled by the growing demand for advanced medical treatments, rising healthcare needs, and the search for innovative solutions to complex health challenges. In vitro lung models play a crucial role in clinical trials by providing a controlled setting to examine how substances affect lung tissue, aiding in drug testing, assessing toxicity, modeling diseases, and understanding disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, as of January 2024, there were 477,230 registered clinical trials globally, up from 437,508 in 2022. Consequently, the rise in clinical studies stimulates the in vitro lung model market.

Key players in the in vitro lung model market are developing 3D respiratory tissue models to enhance the physiological relevance and complexity of their models. These models are created by culturing selected respiratory cells in a specialized environment, allowing them to form a three-dimensional structure that mimics the function and morphology of the respiratory system. This provides a more physiologically relevant platform for research and drug testing. For example, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. EpiNasal replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and beating cilia. The introduction of EpiNasal expands MatTek's range of 3D respiratory tissue models, offering a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

In March 2021, CELLINK, a US-based bioconvergence company, acquired MatTek Corporation for an undisclosed sum. Through this acquisition, CELLINK aims to merge its expertise in lab-engineered human tissue with bioprinting technology to pioneer alternative test models, thereby reducing reliance on animal testing. This aligns with their vision of revolutionizing medicine through accurate, ethical testing and expanding scientific impact. MatTek Corporation is a US-based biotechnology company specializing in in vitro human tissue model innovation as a reliable alternative to animal testing.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc. , STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Lung Model Market Characteristics

3. In-Vitro Lung Model Market Trends And Strategies

4. In-Vitro Lung Model Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global In-Vitro Lung Model Market Size and Growth

  • 5.1. Global In-Vitro Lung Model Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global In-Vitro Lung Model Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global In-Vitro Lung Model Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. In-Vitro Lung Model Market Segmentation

  • 6.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Two-Dimensional (2D) Model
  • Three-Dimensional (3D) Model
  • 6.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Discovery And Toxicology Studies
  • Physiological Research
  • Three-Dimensional (3D) Model Development
  • Other Applications
  • 6.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users

7. In-Vitro Lung Model Market Regional And Country Analysis

  • 7.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific In-Vitro Lung Model Market

  • 8.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China In-Vitro Lung Model Market

  • 9.1. China In-Vitro Lung Model Market Overview
  • 9.2. China In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India In-Vitro Lung Model Market

  • 10.1. India In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan In-Vitro Lung Model Market

  • 11.1. Japan In-Vitro Lung Model Market Overview
  • 11.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia In-Vitro Lung Model Market

  • 12.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia In-Vitro Lung Model Market

  • 13.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea In-Vitro Lung Model Market

  • 14.1. South Korea In-Vitro Lung Model Market Overview
  • 14.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe In-Vitro Lung Model Market

  • 15.1. Western Europe In-Vitro Lung Model Market Overview
  • 15.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK In-Vitro Lung Model Market

  • 16.1. UK In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany In-Vitro Lung Model Market

  • 17.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France In-Vitro Lung Model Market

  • 18.1. France In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy In-Vitro Lung Model Market

  • 19.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain In-Vitro Lung Model Market

  • 20.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe In-Vitro Lung Model Market

  • 21.1. Eastern Europe In-Vitro Lung Model Market Overview
  • 21.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia In-Vitro Lung Model Market

  • 22.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America In-Vitro Lung Model Market

  • 23.1. North America In-Vitro Lung Model Market Overview
  • 23.2. North America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA In-Vitro Lung Model Market

  • 24.1. USA In-Vitro Lung Model Market Overview
  • 24.2. USA In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada In-Vitro Lung Model Market

  • 25.1. Canada In-Vitro Lung Model Market Overview
  • 25.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America In-Vitro Lung Model Market

  • 26.1. South America In-Vitro Lung Model Market Overview
  • 26.2. South America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil In-Vitro Lung Model Market

  • 27.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East In-Vitro Lung Model Market

  • 28.1. Middle East In-Vitro Lung Model Market Overview
  • 28.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa In-Vitro Lung Model Market

  • 29.1. Africa In-Vitro Lung Model Market Overview
  • 29.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Lung Model Market Competitive Landscape
  • 30.2. In-Vitro Lung Model Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Lonza Group AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. PerkinElmer Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Charles River Laboratories International Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Varian Medical Systems Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. In-Vitro Lung Model Market Other Major And Innovative Companies

  • 31.1. Epithelix
  • 31.2. The Charles Stark Draper Laboratory Inc.
  • 31.3. STEMCELL Technologies
  • 31.4. American Type Culture Collection (ATCC)
  • 31.5. BioIVT
  • 31.6. InSphero
  • 31.7. Emulate Inc.
  • 31.8. PhoenixBio Co. Ltd.
  • 31.9. Newcells Biotech
  • 31.10. CN Bio Innovations Ltd.
  • 31.11. Mimetas
  • 31.12. Cyfuse Biomedical K.K.
  • 31.13. 3D Biotek LLC
  • 31.14. AlveoliX AG
  • 31.15. AxoSim Technologies LLC

32. Global In-Vitro Lung Model Market Competitive Benchmarking

33. Global In-Vitro Lung Model Market Competitive Dashboard

34. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

35. In-Vitro Lung Model Market Future Outlook and Potential Analysis

  • 35.1 In-Vitro Lung Model Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Lung Model Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Lung Model Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer